Regulation of the CYP1A1 gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin but not by β-naphthoflavone or 3-methylcholanthrene is altered in hepatitis C virus replicon-expressing cells

Molecular Pharmacology

Volumn 70, Issue 3, 2006, Pages 1062-1070

  Anderson, Garret R ^a   Hasan, Aliya ^a   Yin, Hao ^a   Qadri, Ishtiaq ^a   Quattrochi, Linda C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; ACETYLCYSTEINE; BETA NAPHTHOFLAVONE; CYTOCHROME P450 1A1; NORDIHYDROGUAIARETIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE CONTROL; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BETA-NAPHTHOFLAVONE; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HEPACIVIRUS; HUMANS; LIGANDS; METHYLCHOLANTHRENE; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON; REPLICON; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 33747596890     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.024125     Document Type: Article

References (39)

1. Ali HA, el-Yazigi A, Sieck JO, Ali MA, Raines DA, Saour J, Ernst P, Khan B, and Dossing M (1995) Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C. J Hepatol 22:17-21.
2. Alter HJ (1995) To C or not to C: There are questions. Blood 85:1681-1695.
3. Auyeung DJ, Kessler FK, and Ritter JK (2003) Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the aryl hydrocarbon receptor pathway. Mol Pharmacol 63:119-127.
4. Backlund M and Ingelman-Sundberg M (2004) Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Mol Pharmacol 65:416-425.
5. Barouki R and Morel Y (2001) Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 61:511-516.
6. Becquemont L, Chazouilleres O, Serfaty L, Poirier JM, Broly F, Jaillon P, Poupon R, and Funck-Brentano C (2002) Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C. Clin Pharmacol Ther 71:488-495.
7. Blight KJ, Kolykhalov AA, and Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science (Wash DC) 290:1972-1974.
8. Burbach KM, Poland A, and Bradfield CA (1992) Cloning of the AH-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89:8185-8189.
9. DeMaria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, and Floyd RA (1996) Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 21:291-295.
10. Denison MS, Fisher JM, and Whitlock JP Jr (1988) Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc Natl Acad Sci USA 85:2528-2532.
11. Denison MS and Whitlock JP Jr (1995) Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270:18175-18178.
12. Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, and Hakansson H (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207:1-24.
13. Gollapudi S, Kim CH, Patel A, Sindhu R, and Gupta S (1996) Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-κB Activity and production of tumor necrosis factor-α. Biochem Biophys Res Commun 226:889-894.
14. Gong G, Waris G, Tanveer R, and Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci USA 98:9599-9604.
15. Gonzalez FJ and Gelboin HV (1991) Human cytochromes P450: evolution, catalytic activities and interindividual variations in expression. Prog Clin Biol Res 372:11-20.
16. Hayashibara T, Yamada Y, Mori N, Harasawa H, Sugahara K, Miyanishi T, Kamihira S, and Tomonaga M (2003) Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. Biochem Biophy Res Commun 300:128-134.
17. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, and Dhumeaux D (2003) Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 52:126-129.
18. Jorquera F, Almar M, Diaz-Golpe V, Olcoz JL, Garcia-Fernandez A, and Gonzalez-Gallego J (2001) Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy. Am J Gastroenterol 96:2456-2461.
19. Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, and Alaoui-Jamali MA (1996) Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Toxicol Pathol 24:458-467.
20. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, and Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (Wash DC) 285:110-113.
21. Murayama T, Inoue M, Nomura T, Mori S, and Eizuru Y (2002) 2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line. Biochem Biophy Res Commun 296:651-656.
22. Nebert DW, Dalton TP, Okey AB, and Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847-23850.
23. Ogiso H, Kagi N, Matsumoto E, Nishimoto M, Arai R, Shirouzu M, Mimura J, Fujii-Kuriyama Y, and Yokoyama S (2004) Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 43:15510-15519.
24. Ohata H, Tetsuka T, Hayashi H, Onozaki K, and Okamoto T (2003) 3-Methylcholanthrene activates human immunodeficiency virus type 1 replication via aryl hydrocarbon receptor. Microbiol Immunol 47:363-370.
25. Pasanen M, Rannala Z, Tooming A, Sotaniemi EA, Pelkonen O, and Rautio A (1997) Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. Toxicology 123:177-184.
26. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, Rueff B, Valla DC, and Degos F (2001) Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34:121-125.
27. Postlind H, Vu TP, Tukey RH, and Quattrochi LC (1993) Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 118:255-262.
28. Puga A, Maier A, and Medvedovic M (2000) The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem Pharmacol 60:1129-1142.
29. Qadri I, Iwahashi M, Capasso JM, Hopkin MW, Flores S, Schaack J, and Simon FR (2004) Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J 378:919-928.
30. Quattrochi LC, Okino ST, Pendurthi UR, and Tukey RH (1985) Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA 4:395-400.
31. Renton KW (2004) Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 5:235-243.
32. Schlezinger JJ, White RD, and Stegeman JJ (1999) Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3′,4,4′- tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As. Mol Pharmacol 56:588-597.
33. Shertzer HG, Nebert DW, Puga A, Ary M, Sonntag D, Dixon K, Robinson LJ, Cianciolo E, and Dalton TP (1998) Dioxin causes a sustained oxidative stress response in the mouse. Biochem Biophys Res Commun 253:44-48.
34. Strassburg CP, Oldhafer K, Manns MP, and Tukey RH (1997) Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 52:212-220.
35. Sugatani J, Yamakawa K, Tonda E, Nishitani S, Yoshinari K, Degawa M, Abe I, Noguchi H, and Miwa M (2004) The induction of human UDP- glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 67:989-1000.
36. Tsunedomi R, Iizuka N, Hamamoto Y, Uchimura S, Miyamoto T, Tamesa T, Okada T, Takemoto N, Takashima M, Sakamoto K, et al. (2005) Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. Int J Oncol 27:661-667.
37. Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, and Nebert DW (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 65:225-237.
38. Waris G, Tardif KD, and Siddiqui A (2002) Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol 64:1425-1430.
39. Yao Y, Hoffer A, Chang C-Y, and Puga A (1995) Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. Environ Health Perspect 103:366-371.